News FDA Approves Ocriplasmin for Vitreomacular Adhesions by Medscape • 2012/10/18 • 0 Comments The FDA has approved ocriplasmin intravitreal injection for the treatment of symptomatic vitreomacular adhesions. FDA Approvals Full Story →